Management Team
-
Philip Breitfeld, MD
Chief Medical Officer
Over 30 years of oncology drug development experience across academia, pharma, biotech and CROs including Merck KGaA and Quintiles.
-
Sougata Dey, PhD
Director of Chemistry
Specializes in oligonucleotide therapeutics, with expertise in radiochemistry, synthetic medicinal chemistry, molecular biology, and nucleic acid chemistry. 15+ years of experience.
-
Jagruti Harkleroad
Program Analyst
Jagruti is an accomplished biomedical researcher with nearly a decade of experience in drug discovery, preclinical development, and project management.
-
Michael J. Heffernan, PhD, PE
Vice President of Operations
Over 30 years research, product development and operations experience at large and startup company settings.
-
Secondra Holmes, PhD
Product Development Associate
Expert in pharmacology and chemical biology with over a decade of drug discovery experience.
-
Serena Miggins, MA
Business Operations Manager
Serena brings over a decade of experience in optimizing business processes and driving operational excellence.
-
Uksha Saini, PhD
Senior Scientist, Non-Clinical
Over 15 years of oncology research and drug development experience across multiple cancers.
-
Atul Varadhachary, MD, PhD
Chief Executive Officer
25 years of oncology drug development including a Phase 3 exit. Veteran of Agennix, Reliance Life Sciences, McKinsey, and Fannin.
-
Mark Worscheh, MBA
Chief Financial Officer
As an investment banker and seasoned financial executive, Mark brings a wealth of expertise to the role of CFO, having successfully steered the financial strategies of multiple venture-backed startups over the past 25 years.